MedPath

Ondensetron verses Dexamethasone and Ondensetron combination for nausea and vomitting-A study

Phase 2
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2020/11/029051
Lead Sponsor
ikhil Mudgalkar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The inclusion criteria of the patients were Patients of ASA grade I and II, Patients between 20 to 45 years of age ,Patients weighing between 30 to 70 kilogram

Exclusion Criteria

Patients belonging to ASA grade III and IV,Patients who are obese,Pregnant women,Patients with history of motion sickness,Patients who have received antiemetic within 24 hours of surgery,Patients on chronic steroid therapy,Patients suffering from diabetes mellitus, intestinal obstruction and hiatus hernia, renal and hepatic diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of episodes of emesis and nausea will be recordedTimepoint: every 1 hour till first 4 hour <br/ ><br>then every 4 hourly till next 24 hours
Secondary Outcome Measures
NameTimeMethod
any side effects of the drug <br/ ><br>need for rescue antiemeticTimepoint: upto 24 hours
© Copyright 2025. All Rights Reserved by MedPath